JPMorgan Forecast Over 85% Upside for Two Biopharma Stocks Targeting Obesity and Chronic Conditions

JPMorgan Forecast Over 85% Upside for Two Biopharma Stocks Targeting Obesity and Chronic Conditions

This year’s steady climb of the S&P 500 index has market experts forecasting a robust remainder of 2024. JPMorgan analyst Madison Faller recently highlighted that the S&P 500 has gained over 10% in 100 trading days, and whenever that has happened since 1950, “stocks have closed out the full year with an average return of … Read more

I’m a founder living with chronic illness. Here’s how I thrive

I’m a founder living with chronic illness. Here’s how I thrive

I was lying in a hospital bed. The smell of antiseptic overwhelmed my senses. An IV pierced my arm and pumped morphine through my veins to dull the agonizing pain.  After nearly three weeks in the hospital, with no answers, the doctors finally figured out it wasn’t “all in my head.” They found bleeding ulcers … Read more